Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors

Abstract

SII was a robust indicator of tumor differentiation and one-year survival in elderly patients with newly diagnosed solid tumors. Patients in the high SII group showed poor tumor differentiation and poor prognosis compared to patients with a low SII score.